Whalegun
Home

Gwenn Hansen, Chief Scientific Officer: Nurix Therapeutics NRIX Sell · Filed 06/25

Trade details

Type
Insider sale
Amount
$107,880
Shares · price
5,394 sh · $20.00 a share
Held after
115,005 sh
Stock
Nurix Therapeutics NRIX
Person
Gwenn HansenChief Scientific Officer
Trade date
26/06/25
Filed
26/06/25
Days to filing
0 days

Sold 4.5% of holdings

Share of holding sold
4.5%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Gwenn Hansen's recent trades

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $215.1K

    Filed 08/05

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $95.5K

    Filed 08/04

  • Gwenn Hansen

    Planned sale10b5-1 planNurix Therapeutics

    $104.1K

    Filed 06/25

  • Gwenn Hansen

    SellNurix Therapeutics

    $53.5K

    Filed 04/30

  • Gwenn Hansen

    SellNurix Therapeutics

    $79.5K

    Filed 01/30